TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 11 | 22 | 14 | 4 | -26 | -35 | -2 |
| P | %wins | 100 | 100 | 100 | 67 | 0 | 0 | 61 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/6/16 16:15 | 9/1/16 | COCP | Cocrystal Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wilcox Gary | GA | DO | INTERIM | P | 4 | 0.4100 | 0 | 10 | 0 | 16,949 | I | 34 | -43 | -11 | -20 | 9 | 13 | 28 | 24 | 8 | 0 | 2 | -8 | ||
3/17/16 16:05 | 3/15/16 | COCP | Cocrystal Pharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Wilcox Gary | GA | D | P | 25 | 0.5100 | 0 | 49 | 0 | 16,939 | D | 11 | -40 | -10 | -10 | 5 | 9 | 7 | -5 | 0 | 25 | 18 | 2 | -20 | ||
3/27/15 16:18 | 3/25/15 | COCP | Cocrystal Pharma, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Wilcox Gary | WA | DO | CEO | P | 50 | 0.9200 | 1 | 54 | 0 | 16,890 | D | -6 | 71 | 154 | 120 | 43 | 10 | -3 | -1 | 24 | 42 | 23 | 17 | -32 | -35 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |